Mpm. Stokkel et al., Preoperative evaluation of patients with primary head and neck cancer using dual-head (18)fluorodeoxyglucose positron emission tomography, ANN SURG, 231(2), 2000, pp. 229-234
Objective
To evaluate the value of (18)fluorodeoxyglucose (FDG) positron emission tom
ography (PET) in primary head acid neck cancer.
Background Data
Head and neck carcinomas tend to metastasize to regional lymph nodes rather
than to spread hematogenously. With nodal metastases, cure rates decrease
by approximately 50%. Moreover, in approximately 3% of the patients, a seco
nd primary tumor is found at initial presentation.
Methods
Fifty-four consecutive patients (31 men and 23 women; mean age 60 years, ra
nge 34-81 years) with previously untreated squamous cell carcinomas of the
oral cavity or oropharynx were studied. Before surgery and within a period
of 3 weeks, clinical examination, chest x-ray, computed tomography (CT), ul
trasonography with fine-needle aspiration cytology (US/ FNAC), and FDG-PET
were performed. All study results were scored per neck side and were also c
lassified as 0 (no metastases), 1 (single metastasis), or 2 (multiple metas
tases).
Results
The sensitivity for the detection of lymph node metastases per neck side wa
s 96%, 85%, and 64% for FDG-PET, CT, and US/FNAC, respectively. The specifi
city was 90%, 86%, and 100% for FDG-PET, CT, and US/FNAC, respectively. In
terms of the classification, FDG-PET showed the best correlation with the h
istologic data. Finally, in nine patients (17%), a second primary tumor was
detected by FDG-PET and confirmed by histologic evaluation,
Conclusion
Because of the high prevalence of second primary tumors detected by FDG-PET
and the decreased error rate in the assessment of lymph node involvement c
ompared with CT and US, FDG-PET should be routinely performed in patients w
ith primary head and neck cancer.